Guillain-Barre syndrome: How well is it being managed?
Study shows outcomes from a case series at a major Australian hospital
The first research on outcomes of Australian patients with Guillain-Barre syndrome in three decades shows treatment appears to be working well, with no deaths during the study period.
Clinicians at Sydney’s Royal North Shore Hospital analysed records for the 46 people with the condition (54% male, mean age 55 years) presenting at the hospital between 2012 and 2016.
Treatment was by immunotherapy in 98%, with 93% having intravenous immunoglobulin (IVIG).
Some 17% of patients showed no improvement after their first IVIG treatment, and most of these patients had further therapy. Just 13% of all patients needed care in ICU.
